Artiva Biotherapeutics (ARTV) Income Statement: Revenue & Earnings

Artiva Biotherapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Artiva Biotherapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.25	33.49	4.93	2.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.25	33.49	4.93	2.00	0.00
Operating Expenses
Research & Development	50.33	50.25	43.98	42.41	13.85
Selling, General & Administrative	17.21	13.91	20.78	12.86	4.43
Operating Expenses	67.53	64.16	64.76	55.27	18.27
Operating Income	-67.28	-30.67	-59.83	-53.27	-18.27
Other Income/Expense
Interest Income	5.35	2.54	-1.29	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.20
Other Income/Expense	8.79	-0.97	0.20	-18.55	0.48
Income
Income Before Tax	-58.49	-28.65	-60.92	-71.83	-17.99
Income Tax Expense	0.00	0.07	0.05	0.00	0.00
Net Income	-58.49	-28.72	-60.98	-71.83	-17.99
Net Income - Continuous Operations	-58.49	-32.77	-60.98	-71.83	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-64.85	-28.41	-58.67	-53.02	-18.20
EBIT	-68.90	-30.67	-59.83	-53.27	-18.27
Depreciation & Amortization	2.43	2.27	1.16	0.25	0.07
Earnings Per Share
Basic EPS	-5.00	-36.00	-7.00	-105.00	-28.00
Diluted EPS	-5.00	-36.00	-7.00	-105.00	-28.00
Basic Shares Outstanding	24.36	0.80	9.36	0.69	0.63
Diluted Shares Outstanding	24.36	0.80	9.36	0.69	0.63